arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Biofrontera Inc.

BFRI

$0.82 ▼ -0.08 (-8.79%) at close

7 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Biofrontera Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $8.3M

Dividend Yield —

Revenue Growth 11.7% ↗

Op. Margin -27.2% ↗

ROIC -108.5% ↗

FCF / Share $-1.31 ↗

Trailing P/E —

Price / Book 0.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$41.70M

↑ +11.7% —

Net Income Profit after all expenses

$-10.54M

↑ +40.7% —

Operating Margin Operating profit as % of sales

-27.2%

↑ +41.0% 8th

FCF / Share Free cash flow per share

$-1.31

↑ +29.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	11.7% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+47%)	9.5% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+19%)	18.8% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+135%)	19.0% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+137%)	27.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+248%)	—	—
EPS Growth YoY (%)	67.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	75.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-2034.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	85.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	40.7% Excellent ↑ Excellent Improving Year-over-year change in net income	11.8% Fair ↑ Fair Improving Year-over-year change in net income	-3045.5% Weak ↓ Weak Declining Year-over-year change in net income	98.3% Excellent Excellent Year-over-year change in net income	-243.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	29.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	88.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-4.8% Weak Weak Year-over-year change in free cash flow	-406.5% Weak Weak Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	13.3% Good ↓ Good Declining Compound annual revenue growth over 3 years	15.7% Excellent Excellent Compound annual revenue growth over 3 years	21.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	17.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	-27.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-281%)	-46.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-407%)	-66.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-544%)	-64.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-532%)	-104.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-797%)	-51.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-440%)	—
Effective Tax Rate (%) (%)	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-25.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-311%)	-47.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-497%)	-59.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-592%)	-2.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-119%)	-156.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1404%)	-58.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-586%)	—
FCF Margin (%) (%)	-32.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-27.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-73.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-56.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-110.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-65.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.27x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.24x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	25.37x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-108.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-388.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-473.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-81.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-222.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-165.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-39.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-77.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-81.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-39.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-100.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-770%)	—	—	-2.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-118%)	—	-188.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1357%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	—	—	0.81x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+36%)	—	—	—	—
Interest Coverage (x)	-1891.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9.96x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-103.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1548.42x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-73.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	-3.35x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-6.39M	$-5.91M	$2.56M	$-17.21M	$-24.55M	$-8.08M	—
Debt / EBITDA (x)	—	—	-0.17x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$4.10	$6.77	$22.03	$27.13	$2.74	—	—
Basic EPS, GAAP (USD)	$-1.04	$-3.22	$-13.02	$-0.61	$-4.28	—	—
Free Cash Flow per Share (USD)	$-1.31	$-1.86	$-16.10	$-15.36	$-3.03	—	—
Book Value per Share (USD)	$0.90	$0.50	$3.16	$17.89	$0.66	$0.73	—
Tangible Book Value per Share (USD)	$0.67	$0.50	$1.43	$15.62	$0.46	$0.24	—
Basic Weighted Avg Shares (shares)	10.17M	5.52M	1.55M	1.06M	8.81M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$6.19M	$8.68M	$4.99M	$22.25M	$32.59M	$15.16M	—
Total Equity (USD)	$10.48M	$4.43M	$4.79M	$23.88M	$11.34M	$5.83M	$-30.18M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$41.70M	$37.32M	$34.07M	$28.67M	$24.10M	$18.85M	—
Depreciation Expense (USD)	$138.00K	$421.00K	$86.00K	$101.00K	$122.00K	$144.00K	—
Net Income, GAAP (USD)	$-10.54M	$-17.76M	$-20.13M	$-640.00K	$-37.71M	$-10.99M	—
Operating Cash Flow (USD)	$-13.36M	$-10.27M	$-24.89M	$-16.20M	$-26.71M	$-12.37M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 26 quarters

Biofrontera Inc.

Analytical Summary

7-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BFRI with peers